Migraine (Pediatric) Clinical Trials

A listing of Migraine (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 49 clinical trials
Featured trial
Pediatric Migraine Research Study

It's estimated that upwards of 28% of adolescents will experience migraines. Because of this, migraines are ranked as one of the top five health issues affecting children. If your child struggles with migraine symptoms, they may be eligible for a research study evaluating a study medication. This study is being …

  • 69 views
  • 23 Nov, 2020
  • 1 location
Featured trial
BHV3000-312

Adolescent migraine

  • 0 views
  • 09 Aug, 2022
  • 1 location
Biomarker and Genetic Predictors of Erenumab Treatment Response

To explore the relationship between clinical response to erenumab and genetic biomarkers

erenumab
headache
  • 0 views
  • 09 Dec, 2021
  • 4 locations
Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature

Migraine is a highly prevalent and disabling neurological disease, which has a tremendous impact on sufferers, healthcare systems, and the economy. According to the 2016 WHO report, migraine is the second leading cause of years lived with disability, greater than all other neurological diseases combined. Yet, the treatment in migraine …

  • 0 views
  • 24 Apr, 2021
  • 1 location
A Phase 3, Randomized, Double-blind,Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM]) (OASIS(EM))

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with episodic migraine. The study hypothesis is that in pediatric subjects with episodic migraine, the combined erenumab dose group has a greater reduction from baseline …

erenumab
photophobia
phonophobia
episodic migraine
headache
  • 258 views
  • 21 Oct, 2022
  • 75 locations
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2 (PIONEER-PEDS2)

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

acute treatment
lasmiditan
ly573144
migraine in children
  • 176 views
  • 24 Oct, 2022
  • 172 locations
A Phase 2/3 Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

The purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.

  • 125 views
  • 20 Oct, 2022
  • 89 locations
Comprehensive Assessment of Erenumab Efficacy in Subjects With High Frequency Episodic Migraine With at Least 1 Previously Failed Preventive Treatment: a Global, Double-blind, Placebo-controlled Phase 4 Study (EMBRACE)

The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.

eletriptan
rizatriptan
acute treatment
moderate pain
acute migraine
  • 366 views
  • 23 Oct, 2022
  • 64 locations
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of episodic migraine (EM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of EM, to evaluate the safety and …

recurrent headaches
episodic migraine
fremanezumab
daily headaches
headache
  • 126 views
  • 04 Oct, 2022
  • 74 locations
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine (OASIS (CM))

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with chronic migraine. The study hypothesis is that in pediatric subjects with chronic migraine, the combined erenumab dose group has a greater reduction from baseline …

erenumab
headache
chronic migraine
  • 422 views
  • 07 Oct, 2022
  • 70 locations